Hypothalamic obesity: Prevalence, associations and longitudinal trends in weight in a specialist adult neuroendocrine clinic

European Journal of Endocrinology

Volumn 168, Issue 4, 2013, Pages 501-507

  Steele, Caroline A ^a   Cuthbertson, Daniel J ^a   MacFarlane, Ian A ^a   Javadpour, Mohsen ^b   Das, Kumar S V ^b   Gilkes, Catherine ^b   Wilding, John P ^a   Daousi, Christina ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; GROWTH HORMONE; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN; THYROXINE;

ADULT; AWARENESS; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DISEASE ASSOCIATION; DRUG USE; EARLY INTERVENTION; FEMALE; FOLLOW UP; HUMAN; HYPOTHALAMUS LESION; HYPOTHALAMUS TUMOR; MALE; MORBID OBESITY; MULTIVARIATE ANALYSIS; NEUROIMAGING; OBESITY; PATHOPHYSIOLOGY; PATIENT COUNSELING; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; AGED; COHORT STUDIES; ENDOCRINE SYSTEM DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHALAMIC DISEASES; LONGITUDINAL STUDIES; MALE; MEDICINE; MIDDLE AGED; OBESITY; OUTPATIENT CLINICS, HOSPITAL; PREVALENCE; RETROSPECTIVE STUDIES; WEIGHT GAIN;

EID: 84875123229     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0792     Document Type: Review

References (40)

1. Daousi C, Dunn AJ, Foy PM, MacFarlane IA & Pinkney JH. Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage. American Journal of Medicine 2005 118 45-50. (doi:10.1016/j.amjmed.2004.06.035)
2. Daousi C, MacFarlane IA, English PJ, Wilding JP, Patterson M, Dovey TM, Halford JC, Ghatei MA & Pinkney JH. Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage? Journal of Clinical Endocrinology and Metabolism 2005 90 5025-5030. (doi:10.1210/jc.2004-1874)
3. Deepak D, Furlong NJ, Wilding JP & MacFarlane IA. Cardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary disease. Postgraduate Medical Journal 2007 83 277-280. (doi:10.1136/pgmj.2006.052241)
4. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC & Stewart PM. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001 357 425-431. (doi:10.1016/S0140-6736(00)04006-X)
5. Department of Health: Health Survey for England. Body Mass Index (BMI), by survey year, age and sex. Available at: http://www.doh.gov.uk/stats/tables/ trendtab.xls. Accessed August, 2012.
6. Bulow B, Attewell R, Hagmar L, Malmstrom P, Nordstrom CH & Erfurth EM. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. Journal of Clinical Endocrinology and Metabolism 1998 83 3897-3904. (doi:10.1210/jc.83.11.3897)
7. Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW & Cowell CT. Features of the metabolic syndrome after childhood craniopharyngioma. Journal of Clinical Endocrinology and Metabolism 2004 89 81-86. (doi:10.1210/jc.2003- 030442)
8. Holmer H, Ekman B, Björk J, Nordstöm CH, Popovic V, Siversson A & Erfurth EM. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on longterm GH therapy. European Journal of Endocrinology 2009 161 671-679. (doi:10.1530/EJE-09-0449)
9. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH & American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006 113 898-918. (doi:10.1161/CIRCULATIONAHA.106. 171016)
10. De Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG & Stanhope R. Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. Journal of Clinical Endocrinology and Metabolism 1996 81 2734-2737. (doi:10.1210/jc.81.7.2734)
11. Meuric S, Brauner R, Trivin C, Souberbielle JC, Zerah M & Sainte- Rose C. Influence of tumor location on the presentation and evolution of craniopharyngiomas. Journal of Neurosurgery 2005 103 421-426.
12. Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. Journal of Neurosurgery 2007 106 3-12.
13. Van Gompel JJ, Nippoldt TB, Higgins DM & Meyer FB. Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity. Neurosurgical Focus 2010 28 E3. (doi:10.3171/2010.1.FOCUS09303)
14. Sainte-Rose C, Puget S, Wray A, Zerah M, Grill J, Brauner R, Boddaert N & Pierre-Kahn A. Craniopharyngioma: the pendulum of surgical management. Child's Nervous System 2005 21 691-695. (doi:10.1007/s00381-005-1209-2)
15. Lee M & Korner J. Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans. Pituitary 2009 12 87-95. (doi:10.1007/s11102-008-0096-4)
16. Muller HL. Consequences of craniopharyngioma surgery in children. Journal of Clinical Endocrinology and Metabolism 2011 96 1981-1991. (doi:10.1210/jc.2011-0174)
17. Roth CL, Gebhardt U & Muller HL. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity 2011 19 36-42. (doi:10.1038/oby. 2010.80)
18. Lustig RH. Hypothalamic obesity: causes, consequences, treatment. Pediatric Endocrinology Reviews 2008 6 220-227.
19. Pinkney J, Wilding J, Williams G & MacFarlane I. Hypothalamic obesity in humans: what do we know and what can be done? Obesity Reviews 2002 3 27-34. (doi:10.1046/j.1467-789X.2002.00052.x)
20. Hochberg I & Hochberg Z. Expanding the definition of hypothalamic obesity. Obesity Reviews 2010 11 709-721. (doi:10.1111/j.1467-789X.2010.00727.x)
21. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL & Kun LE. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. Journal of Pediatrics 1999 135 162-168. (doi:10.1016/S0022-3476(99)70017-X)
22. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S & Xiong X. Octreotide therapy of pediatric hypothalamic obesity: a doubleblind, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 2003 88 2586-2592. (doi:10.1210/jc.2002-030003)
23. Arango C, Rojas MJ, Moreno D & Parellada M. Sibutramine for compulsive eating in hypothalamic deficiency. Journal of the American Academy of Child and Adolescent Psychiatry 2002 41 1147-1148. (doi:10.1097/00004583- 200210000-00004)
24. Danielsson P, Janson A, Norgren S & Marcus C. Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. Journal of Clinical Endocrinology and Metabolism 2007 92 4101-4106. (doi:10.1210/jc.2007-0826)
25. Mason PW, Krawiecki N & Meacham LR. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Archives of Pediatrics & Adolescent Medicine 2002 156 887-892.
26. Ismail D, O'Connell MA & Zacharin MR. Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury. Journal of Pediatric Endocrinology & Metabolism 2006 19 129-134.
27. Igaki N, Tanaka M & Goto T. Markedly improved glycemic control and enhanced insulin sensitivity in a patient with type 2 diabetes complicated by a suprasellar tumor treated with pioglitazone and metformin. Internal Medicine 2005 44 832-837. (doi:10.2169/internalmedicine.44.832)
28. Thondam SK, Cuthbertson DJ, Aditya BS, MacFarlane IA, Wilding JP & Daousi C. A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment of hypothalamic obesity complicated by type 2 diabetes mellitus. Clinical Endocrinology 2012 77 635-637. (doi:10.1111/j.1365-2265.2012.04368.x)
29. Fernandes JK, Klein MJ, Ater JL, Kuttesch JF & Vassilopoulou- Sellin R. Triiodothyronine supplementation for hypothalamic obesity. Metabolism 2002 51 1381-1383. (doi:10.1053/meta.2002.35591)
30. Müller HL, Handwerker G, Gebhardt U, Faldum A, Emser A, Kolb R & Sörensen N. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes & Control 2006 17 583-589. (doi:10.1007/s10552-005-9012-7)
31. Müller HL, Gebhardt U, Wessel V, Schröder S, Kolb R, Sörensen N, Maroske J & Hanisch E. First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klinische Padiatrie 2007 219 323-325. (doi:10.1055/s-2007-985848)
32. Inge TH, Pfluger P, Zeller M, Rose SR, Burget L, Sundararajan S, Daniels SR & Tschöp MH. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nature Clinical Practice. Endocrinology & Metabolism 2007 3 606-609. (doi:10.1038/ncpendmet0579)
33. Schultes B, Ernst B, Schmid F & Thurnheer M. Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. European Journal of Endocrinology 2009 161 201-206. (doi:10.1530/EJE-09-0079)
34. Rottembourg D, O'Gorman CS, Urbach S, Garneau PY, Langer JC, Van Vliet G, Hamilton J & Huot C. Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma. Journal of Pediatric Endocrinology & Metabolism 2009 22 867-872.
35. Tataranni PA, Gautier JF, Chen K, Uecker A, Bandy D, Salbe AD, Pratley RE, Lawson M, Reiman EM & Ravussin E. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. PNAS 1999 96 4569-4574. (doi:10.1073/pnas.96.8.4569)
36. Gautier JF, Del Parigi A, Chen K, Salbe AD, Bandy D, Pratley RE, Ravussin E, Reiman EM & Tataranni PA. Effect of satiation on brain activity in obese and lean women. Obesity Research 2001 9 676-684. (doi:10.1038/oby.2001.92)
37. Killgore WD, Young AD, Femia LA, Bogorodzki P, Rogowska J & Yurgelun-Todd DA. Cortical and limbic activation during viewing of high- versus low-calorie foods. NeuroImage 2003 19 1381-1394. (doi:10.1016/S1053-8119(03) 00191-5)
38. Smeets PA, de Graaf C, Stafleu A, van Osch MJ, Nievelstein RA & van der Grond J. Effect of satiety on brain activation during chocolate tasting in men and women. American Journal of Clinical Nutrition 2006 83 1297-1305.
39. Schur EA, Kleinhans NM, Goldberg J, Buchwald D, Schwartz MW & Maravilla K. Activation in brain energy regulation and reward centers by food cues varies with choice of visual stimulus. International Journal of Obesity 2009 33 653-661. (doi:10.1038/ijo.2009.56)
40. Gautier JF, Chen K, Salbe AD, Bandy D, Pratley RE, Heiman M, Ravussin E, Reiman EM & Tataranni PA. Differential brain responses to satiation in obese and lean men. Diabetes 2000 49 838-846. (doi:10.2337/diabetes.49.5.838)